About St. Jude Pharma Private Limited
Data last updated:
St. Jude Pharma Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24100JK2019PTC010909. Its GSTIN is 01ABBCS8180N1Z3 (Jammu and Kashmir).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sheetal Sharma and Sarveshwar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 116 Shalamar Road Opp S M G S Hospital, Jammu, Jammu and Kashmir, India – 180001.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.69 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹15,427 (net margin 0.8%) and EBITDA of ₹1.62 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 4% over five years.
For more details, the company can be reached via its website stjudepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressH No 116 Shalamar Road Opp S M G S Hospital, Jammu, Jammu and Kashmir, India – 180001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of St. Jude Pharma Private Limited
The main business activity of St. Jude Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of St. Jude Pharma Private Limited FY 2025 filings available
St. Jude Pharma Private Limited reported revenue of ₹19.69 Lakh (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of St. Jude Pharma Private Limited
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of St. Jude Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.62 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15,427 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of St. Jude Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of St. Jude Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of St. Jude Pharma Private Limited
St. Jude Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aushi Immunosciences Private Limited | ₹20.01 Lakh (FY 2024) | •••• | •••• | 202.0% | •••• | Kashipur, Uttarakhand, India |
| Nanotech Medical Solution Private Limited | ₹19.95 Lakh (FY 2019) | •••• | •••• | -89.0% | •••• | Patna, Bihar, India |
| Om Life Care Private Limited | ₹19.95 Lakh (FY 2019) | •••• | •••• | -46.0% | •••• | Jaipur, Rajasthan, India |
| Ayyan Life Sciences Private Limited | ₹19.84 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Karbon Pharma Private Limited | ₹19.78 Lakh (FY 2025) | •••• | •••• | 343.0% | •••• | Chandigarh, India |
| St. Jude Pharma Private Limited this company | ₹19.69 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Jammu, Jammu And Kashmir, India |
| Zeotec Life Science Private Limited | ₹19.68 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Ahmedabad, Gujarat, India |
| Ronson Cellulose Private Limited | ₹19.68 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Ahmedabad, Gujarat, India |
| Primoris Healthcare Private Limited | ₹19.67 Lakh (FY 2024) | •••• | •••• | 79.0% | •••• | Jamnagar, Gujarat, India |
| Vercali Pharma Private Limited | ₹19.66 Lakh (FY 2021) | •••• | •••• | -57.0% | •••• | Hyderabad, Telangana, India |
| SRV Pharma Private Limited | ₹19.66 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below St. Jude Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of St. Jude Pharma Private Limited
St. Jude Pharma Private Limited is audited by V A K & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V A K & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of St. Jude Pharma Private Limited
St. Jude Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sheetal Sharma | Director | 28 Mar 2019 | 7 Years 6 Months | Current |
| Sarveshwar Sharma Also directs: Cheapfaremart Private Limited | Director | 28 Mar 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of St. Jude Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of St. Jude Pharma Private Limited
St. Jude Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at St. Jude Pharma Private Limited
Employment history and EPFO contributions of people linked to St. Jude Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on St. Jude Pharma Private Limited
St. Jude Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sarveshwar Sharma was appointed as Director on 28 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for St. Jude Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by St. Jude Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of St. Jude Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of St. Jude Pharma Private Limited
St. Jude Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01ABBCS8180N1Z3 | Jammu and Kashmir | Active | 26 Apr 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of St. Jude Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about St. Jude Pharma Private Limited
St. Jude Pharma is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 March 2019 (7+ years old) and is registered under CIN U24100JK2019PTC010909.
St. Jude Pharma reported revenue of ₹19.69 Lakh for FY 2025 (down 32% YoY).
St. Jude Pharma has 2 current directors:
- Sheetal Sharma - Director
- Sarveshwar Sharma - Director
St. Jude Pharma reported a net profit of ₹15,427 (net margin 0.8%) and EBITDA of ₹1.62 Lakh (EBITDA margin 8.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of St. Jude Pharma is -22% over three years and 4% over five years. In the latest year (FY 2025) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of St. Jude Pharma is 01ABBCS8180N1Z3, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of St. Jude Pharma is U24100JK2019PTC010909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
St. Jude Pharma was incorporated on 28 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of St. Jude Pharma by revenue are Aushi Immunosciences Private Limited, Nanotech Medical Solution Private Limited, Om Life Care Private Limited, Ayyan Life Sciences Private Limited, Karbon Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Sarveshwar Sharma was appointed as Director on 28 Mar 2019. Sheetal Sharma was appointed as Director on 28 Mar 2019.
St. Jude Pharma can be reached through the website stjudepharma.com. Its registered office is in Jammu, Jammu And Kashmir, India.